Until we have larger, more definitive studies, the safest approach is still to stop GLP-1 medications before trying to conceive. The findings, however, are exactly the kind of data we need to justify properly designed prospective trials, says Lora Shahine, MD, a reproductive endocrinologist and obstetrician-gynecologist at PNWF IVY Fertility Center in Bellevue, Washington, and host of the Brave and Curious podcast
Clinically, GLP-1-based therapies offer the additional advantage of established cardiovascular protection and renal benefits, making them particularly attractive for the large proportion of MASLD patients with comorbid cardiovascular disease or type 2 diabetes
Characterising the genetic architecture of changes in adiposity during adulthood using electronic health records
muciniphila consolidates the intestinal barrier and regulates the balance of pro/anti-inflammatory factors, thereby protecting the host from endotoxemia and metabolic disorders (Figure 3)